|
2021-04-19 |
2021-04-16 |
S
Venta
|
President and Chief Executive
Consejero ejecutivo
|
15 475
+33.7%
93,09
2.761.337 US$
|
15 475
+33.7%
|
93,09
|
2.761.337 US$
|
|
|
2020-10-05 |
2020-10-01 |
B
Compra
|
Consejero no ejecutivo
Gran accionista
|
81 861
-34.3%
256,75
4.585.213 US$
|
81 861
-34.3%
|
256,75
|
4.585.213 US$
|
|
|
2020-10-05 |
2020-10-01 |
B
Compra
|
Consejero no ejecutivo
Gran accionista
|
14 464
+47.2%
33,95
374.856 US$
|
14 464
+47.2%
|
33,95
|
374.856 US$
|
|
|
2020-10-05 |
2020-10-01 |
B
Compra
|
Consejero no ejecutivo
Gran accionista
|
296 296
+inf%
6,00
1.777.776 US$
|
296 296
+inf%
|
6,00
|
1.777.776 US$
|
|
|
2020-10-05 |
2020-10-01 |
B
Compra
|
Consejero no ejecutivo
Gran accionista
|
639 212
+18.3%
6,00
3.835.272 US$
|
639 212
+18.3%
|
6,00
|
3.835.272 US$
|
|
|
2020-10-05 |
2020-10-01 |
B
Compra
|
Consejero no ejecutivo
Gran accionista
|
545 974
+18.3%
6,00
3.275.844 US$
|
545 974
+18.3%
|
6,00
|
3.275.844 US$
|
|
|
2020-10-05 |
2020-10-01 |
B
Compra
|
Consejero no ejecutivo
Gran accionista
|
545 974
+18.3%
6,00
3.275.844 US$
|
545 974
+18.3%
|
6,00
|
3.275.844 US$
|
|
|
2020-10-05 |
2020-09-28 |
S
Venta
|
Gran accionista
|
273 584
-10.3%
7,54
2.061.866 US$
|
273 584
-10.3%
|
7,54
|
2.061.866 US$
|
|
|
2020-10-05 |
2020-09-25 |
S
Venta
|
Gran accionista
|
174 219
-6.2%
7,08
1.232.948 US$
|
174 219
-6.2%
|
7,08
|
1.232.948 US$
|
|
|
2020-10-05 |
2020-09-24 |
S
Venta
|
Gran accionista
|
38 514
-1.3%
7,63
293.823 US$
|
38 514
-1.3%
|
7,63
|
293.823 US$
|
|
|
2020-10-05 |
2020-08-13 |
S
Venta
|
Gran accionista
|
159
-0.0%
8,75
1.391 US$
|
159
-0.0%
|
8,75
|
1.391 US$
|
|
|
2020-10-05 |
2020-08-12 |
S
Venta
|
Gran accionista
|
1 335
-0.0%
8,79
11.735 US$
|
1 335
-0.0%
|
8,79
|
11.735 US$
|
|
|
2020-10-05 |
2020-07-29 |
S
Venta
|
Gran accionista
|
2 709
-0.1%
8,78
23.788 US$
|
2 709
-0.1%
|
8,78
|
23.788 US$
|
|
|
2020-10-05 |
2020-07-22 |
S
Venta
|
Gran accionista
|
22 651
-0.8%
9,00
203.950 US$
|
22 651
-0.8%
|
9,00
|
203.950 US$
|
|
|
2020-10-05 |
2020-07-20 |
S
Venta
|
Gran accionista
|
36 983
-1.3%
9,25
342.056 US$
|
36 983
-1.3%
|
9,25
|
342.056 US$
|
|
|
2020-10-05 |
2020-07-17 |
S
Venta
|
Gran accionista
|
31 101
-1.0%
9,24
287.373 US$
|
31 101
-1.0%
|
9,24
|
287.373 US$
|
|
|
2020-10-05 |
2020-07-16 |
S
Venta
|
Gran accionista
|
16 332
-0.5%
8,56
139.786 US$
|
16 332
-0.5%
|
8,56
|
139.786 US$
|
|
|
2018-10-26 |
2018-10-23 |
B
Compra
|
Arix Bioscience plc
Gran accionista
|
700 000
+30.7%
10,00
7.000.000 US$
|
700 000
+30.7%
|
10,00
|
7.000.000 US$
|
|
|
2018-10-25 |
2018-10-23 |
B
Compra
|
Chimovits Erez
Consejero no ejecutivo
|
490 000
+16.3%
10,00
4.900.000 US$
|
490 000
+16.3%
|
10,00
|
4.900.000 US$
|
|
|
2018-10-25 |
2018-10-23 |
B
Compra
|
Ioannidou Sofia
Consejero no ejecutivo
|
420 000
+30.7%
10,00
4.200.000 US$
|
420 000
+30.7%
|
10,00
|
4.200.000 US$
|
|
|
2018-10-25 |
2018-10-23 |
B
Compra
|
Kariv Tomer
Consejero no ejecutivo
|
100 849
+6.0%
10,00
1.008.490 US$
|
100 849
+6.0%
|
10,00
|
1.008.490 US$
|
|
|
2018-10-25 |
2018-10-23 |
B
Compra
|
Kariv Tomer
Consejero no ejecutivo
|
112 000
+7.1%
10,00
1.120.000 US$
|
112 000
+7.1%
|
10,00
|
1.120.000 US$
|
|
|
2018-10-25 |
2018-10-23 |
B
Compra
|
Kariv Tomer
Consejero no ejecutivo
|
207 151
+15.1%
10,00
2.071.510 US$
|
207 151
+15.1%
|
10,00
|
2.071.510 US$
|
|
|
2018-10-25 |
2018-10-23 |
B
Compra
|
O'Connell Daniel P
Consejero no ejecutivo
|
700 000
+30.7%
10,00
7.000.000 US$
|
700 000
+30.7%
|
10,00
|
7.000.000 US$
|
|
|
2018-10-25 |
2018-10-23 |
B
Compra
|
ORBIMED ADVISORS LLC
Consejero no ejecutivo
Gran accionista
|
700 000
+12.1%
10,00
7.000.000 US$
|
700 000
+12.1%
|
10,00
|
7.000.000 US$
|
|
|
2018-10-25 |
2018-10-23 |
B
Compra
|
ORBIMED ADVISORS LLC
Consejero no ejecutivo
Gran accionista
|
490 000
+9.3%
10,00
4.900.000 US$
|
490 000
+9.3%
|
10,00
|
4.900.000 US$
|
|